SXTC

China SXT Pharmaceuticals (SXTC)

China SXT Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SXTC

1 2 3 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/15	05 : 15	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2024/01/12	06 : 31	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2023/10/27	05 : 05	GlobeNewswire Inc.	China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price Rule	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2023/10/04	21 : 30	GlobeNewswire Inc.	China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Split	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2023/08/01	05 : 15	Edgar (US Regulatory)	Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2023/05/20	06 : 17	Edgar (US Regulatory)	Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2023/05/10	21 : 00	GlobeNewswire Inc.	China SXT Pharmaceuticals, Inc. Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price Rule	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2023/03/30	03 : 20	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2023/03/30	02 : 50	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2023/03/27	19 : 02	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(7) (424b7)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2023/03/01	06 : 06	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2023/02/25	07 : 20	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2023/02/14	06 : 29	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/12/23	20 : 05	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/11/07	22 : 00	GlobeNewswire Inc.	China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/10/12	21 : 46	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/09/27	21 : 01	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/07/19	00 : 02	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/05/19	01 : 30	GlobeNewswire Inc.	China SXT Pharmaceuticals, Inc. Announces 1 for 20 Reverse Share Split	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/05/14	05 : 09	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/05/12	05 : 06	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/03/25	05 : 32	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/03/17	05 : 06	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/03/16	21 : 01	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/03/16	05 : 07	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/03/15	11 : 33	GlobeNewswire Inc.	China SXT Pharmaceuticals, Inc. Enters into Securities Purchase Agreement to Issue a 6% Convertible Promissory Note in the Original Principal Amount of $2.8 Million	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/01/22	07 : 01	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/01/21	20 : 05	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/01/21	01 : 25	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
2022/01/21	00 : 45	GlobeNewswire Inc.	China SXT Pharmaceuticals, Inc. Announces Successful Closing of $4.1 Million Follow-on Underwritten Offering of Ordinary Shares and Pre-Funded Warrants With Simultaneous Exercise of the Over-Allotment	NASDAQ:SXTC	China SXT Pharmaceuticals Inc